NVAX - Novavax Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - NVAX (1000694)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
35 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P25+3-1-10-24
S10-2-4-14-57

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-05-12
NVAXMcManus Michael A JrDirP - Purchase$0.97+20,000277,590+8%+$19,396+8
2017-05-11
NVAXDouglas RichardDirP - Purchase$0.93+200,000550,000+57%+$185,780+8
2017-05-11
NVAXMcManus Michael A JrDirP - Purchase$0.84+10,000257,590+4%+$8,400+12
2017-05-11
NVAXPhillips Barclay ASVP, CFOP - Purchase$0.84+25,00036,612+215%+$20,950+12
2017-05-11
NVAXErck Stanley CPres, CEOP - Purchase$0.84+50,000128,279+64%+$41,980+12
2017-03-14
NVAXYoung James FDirS - Sale$1.39-100,000175,000-36%-$138,980-3-10-35
2017-01-31
NVAXTrizzino JohnSVP, Commercial OperationsP - Purchase$1.12+3,40188,965+4%+$3,809+4+2+15
2017-01-31
NVAXHerrmann John A IIISVP, GCP - Purchase$1.12+4,9607,072+235%+$5,555+4+2+15
2017-01-31
NVAXPhillips Barclay ASVP, CFOP - Purchase$1.12+1,63311,612+16%+$1,829+4+2+15
2016-12-07
NVAXGlenn Gregory MPres, R, DP - Purchase$1.45+1,0004,427+29%+$1,446+7+1+3
2016-09-22
NVAXTrizzino JohnSVP, Commercial OperationsP - Purchase$2.17+46,00085,564+116%+$99,820+4-9-34-46
2016-09-21
NVAXDouglas RichardDirP - Purchase$1.72+100,000350,000+40%+$172,010+5+2-31-46
2016-09-21
NVAXMcManus Michael A JrDirP - Purchase$1.61+30,000247,590+14%+$48,297+5+2-31-46
2016-09-21
NVAXGlenn Gregory MPres, R, DP - Purchase$1.65+1,0003,427+41%+$1,649+5+2-31-46
2016-09-20
NVAXBoudreaux GailDirP - Purchase$1.45+100,000200,000+100%+$144,850+11+24-23-47
2016-07-31
NVAXPhillips Barclay ASVP, CFOP - Purchase$4.29+4229,979+4%+$1,810+6+4-3-80
2016-06-06
NVAXEvans Gary CDirS - Sale$6.50-18,998329,979-5%-$123,487+2-3+14-82
M
2016-05-23
NVAXEvans Gary CDirS - Sale$5.41-50,000348,977-13%-$270,371-3+6+20-82
DM
2016-03-30
NVAXErck Stanley CPres, CEOS - Sale+OE$5.19-424,77878,279-84%-$2,203,619-30-5-64
2016-01-31
NVAXTrizzino JohnSVP, Commercial OperationsP - Purchase$3.63+5,85539,564+17%+$21,254-7-4-7+44
2016-01-31
NVAXHerrmann John A IIISVP, GCP - Purchase$4.38+2,0722,112>999%+$9,075-7-4-7+44
2016-01-31
NVAXGlenn Gregory MSVP, Research, DevelopmentP - Purchase$4.38+2,3692,427>999%+$10,376-7-4-7+44
2016-01-31
NVAXPhillips Barclay ASVP, CFOP - Purchase$4.38+4059,557+4%+$1,774-7-4-7+44
2016-01-31
NVAXErck Stanley CCEO, PresP - Purchase$4.38+2,072103,057+2%+$9,075-7-4-7+44
D
2015-12-16
NVAXGlenn Gregory MSVP, Research, DevelopmentS - Sale+OE$8.58-61,88658-100%-$530,697+1-1-27-20
2015-12-16
NVAXHerrmann John A IIISVP, GCS - Sale$8.64-27,94540-100%-$241,420+1-1-27-20
2015-08-24
NVAXEvans Gary CDirS - Sale$11.24-20,000348,977-5%-$224,808+8-3-16-60
M
2015-08-19
NVAXPhillips Barclay ASVP, CFOS - Sale$13.06-28,6569,152-76%-$374,323-12-4-18-58
D
2015-08-18
NVAXGlenn Gregory MSVP, Research, DevelopmentS - Sale+OE$13.52-15,0001,158-93%-$202,743-1-12-13-55
D
2015-08-13
NVAXEvans Gary CDirS - Sale+OE$13.56-6,002368,977-2%-$81,398-5-15-30-69
2015-07-31
NVAXTrizzino JohnSVP, Commercial OperationsP - Purchase$3.63+5,09833,709+18%+$18,506+2-5-10-58
2015-07-31
NVAXHerrmann John A IIISVP, GCP - Purchase$2.28+1,50227,985+6%+$3,425+2-5-10-58
2015-07-31
NVAXGlenn Gregory MSVP, Research, DevelopmentP - Purchase$2.28+8921,158+335%+$2,034+2-5-10-58
2015-07-31
NVAXPhillips Barclay ASVP, CFOP - Purchase$2.28+76437,808+2%+$1,742+2-5-10-58
2015-07-31
NVAXErck Stanley CCEO, PresP - Purchase$2.28+3,207100,985+3%+$7,312+2-5-10-58

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top